OmniAb, Inc. (OABI) research
OmniAb, Inc.- Sector
- Life Sciences Tools & Services
- Last price
- $4.87
- As of
OmniAb, Inc. (OABI): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-06.
As of . Source: SEC EDGAR filings for OABI. Method and limitations.
Share the OABI intelligence card
See the full OABI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for OABI on one page. Preview it with sample data, then open it live with a free account.
Preview the OABI dossierActive signals for OABI
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +123% to OABI (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +124% to OABI (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 59.2%, EPS $-0.05 vs $-0.1224 estimate
- mediumNEW_POSITION
Point72 Asset Management, L.P. new position in OABI
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate
FREE, NO ACCOUNT
Every signal on OABI, as it fires
You are seeing 5 of 7 signals recorded on OABI since 2026-06-03.
The five above landed across 4 days. The other 2 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in OABI (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 68218J103 · 2026Q2 | $1.6M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 68218J103 · 2026Q2 | $1.5M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 68218J103 · 2026Q2 | $1.4M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 68218J103 · 2026Q2 | $864K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 68218J103 · 2026Q2 | $143K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, OABI
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
OABI against its peers
OABI's operating margin of -369.5% ranks in the 6th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | OABI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 18.7M USD | 1.2B USD | 6 | 25 |
| Gross margin | n/a | 55.5% | n/a | 13 |
| Operating margin | -369.5% | -9.5% | 6 | 23 |
| Net margin | -347.0% | -6.8% | 6 | 25 |
| Return on equity | -24.3% | -7.5% | 38 | 24 |
| P / E | n/a | 44.8x | n/a | 10 |
Peers (25): MLAB, CTKB, PACB, DNA, MRVI, FTRE, CDXS, MXCT, SEER, ABCL, ADPT, SHC, BRKR, AVTR, RGEN, TECH, TXG, CRL, TEM, MEDP, MTD, ILMN, WAT, IQV, A. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (OABI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more OABI signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to OABIand get the insider, 13F, options, and confluence read in one view.